These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11028221)

  • 1. Dissolution properties of piroxicam powders and capsules as a function of particle size and the agglomeration of powders.
    Swanepoel E; Liebenberg W; de Villiers MM; Dekker TG
    Drug Dev Ind Pharm; 2000 Oct; 26(10):1067-76. PubMed ID: 11028221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissolution, bioavailability and ulcerogenic studies on piroxicam-nicotinamide solid dispersion formulations.
    Verma MM; Kumar MT; Balasubramaniam J; Pandit JK
    Boll Chim Farm; 2003 Apr; 142(3):119-24. PubMed ID: 12806831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of formulation and process changes on in vitro dissolution and the bioequivalence of piroxicam capsules.
    Piscitelli DA; Bigora S; Propst C; Goskonda S; Schwartz P; Lesko LJ; Augsburger L; Young D
    Pharm Dev Technol; 1998 Nov; 3(4):443-52. PubMed ID: 9834946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of dissolution rate and anti-inflammatory effects of piroxicam using solvent deposition technique.
    Barzegar-Jalali M; Maleki N; Garjani A; Khandar AA; Haji-Hosseinloo M; Jabbari R; Dastmalchi S
    Drug Dev Ind Pharm; 2002 Jul; 28(6):681-6. PubMed ID: 12149960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid-state dependent dissolution and oral bioavailability of piroxicam in rats.
    Lust A; Laidmäe I; Palo M; Meos A; Aaltonen J; Veski P; Heinämäki J; Kogermann K
    Eur J Pharm Sci; 2013 Jan; 48(1-2):47-54. PubMed ID: 23085546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced oral bioavailability of piroxicam in rats by hyaluronate microspheres.
    Piao MG; Kim JH; Kim JO; Lyoo WS; Lee MH; Yong CS; Choi HG
    Drug Dev Ind Pharm; 2007 Apr; 33(4):485-91. PubMed ID: 17523012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.
    Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C
    Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melt sonocrystallized piroxicam for oral delivery: particle characterization, solid state analysis, and pharmacokinetics.
    Gupta PS; Sharma V; Pathak K
    Expert Opin Drug Deliv; 2013 Jan; 10(1):17-32. PubMed ID: 23102052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piroxicam cocrystals with phenolic coformers: preparation, characterization, and dissolution properties.
    Emami S; Adibkia K; Barzegar-Jalali M; Siahi-Shadbad M
    Pharm Dev Technol; 2019 Feb; 24(2):199-210. PubMed ID: 29557714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative dissolution performance of internationally available piroxicam products.
    Barone JA; Lordi NG; Byerly WG; Colaizzi JL
    Drug Intell Clin Pharm; 1988 Jan; 22(1):35-40. PubMed ID: 3349918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of polymorphism on powder compaction and dissolution properties of chemically equivalent oxytetracycline hydrochloride powders.
    Liebenberg W; de Villiers MM; Wurster DE; Swanepoel E; Dekker TG; Lötter AP
    Drug Dev Ind Pharm; 1999 Sep; 25(9):1027-33. PubMed ID: 10518242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of dissolution and bioavailability of piroxicam in solid dispersion systems.
    Pan RN; Chen JH; Chen RR
    Drug Dev Ind Pharm; 2000 Sep; 26(9):989-94. PubMed ID: 10914324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and evaluation of piroxicam-HPMCAS solid dispersions for ocular use.
    Jachowicz R; Czech A
    Pharm Dev Technol; 2008; 13(6):495-504. PubMed ID: 18720246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An investigation of physicochemical properties of piroxicam liquisolid compacts.
    Javadzadeh Y; Siahi MR; Asnaashari S; Nokhodchi A
    Pharm Dev Technol; 2007; 12(3):337-43. PubMed ID: 17613897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique.
    Maghsoodi M; Sadeghpoor F
    Drug Dev Ind Pharm; 2010 Aug; 36(8):917-25. PubMed ID: 20180658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanocrystals as tool to improve piroxicam dissolution rate in novel orally disintegrating tablets.
    Lai F; Pini E; Angioni G; Manca ML; Perricci J; Sinico C; Fadda AM
    Eur J Pharm Biopharm; 2011 Nov; 79(3):552-8. PubMed ID: 21820052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piroxicam loaded polymer hybrid microspheres based tablets with modified release kinetics: Development, characterization and in vivo evaluation.
    Hamid HA; Khan S; Noor Shah SM; Asghar M; Shahid M; Hussain Z; Sohail M; Khan BA; Amin F; Jan SU; Elhissi A; Shah SMH; Minhas MU; Shah SWA; Ahmad N
    Pak J Pharm Sci; 2021 Jan; 34(1(Supplementary)):327-335. PubMed ID: 34275858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Powder modificationfor improving content uniformity of Ziyin Yiwei Capsules].
    Chen ZZ; Yang RP; Shi YJ; Jia XB; Guo DY; Zou JB; Feng L; Zhao ZP
    Zhongguo Zhong Yao Za Zhi; 2021 Dec; 46(23):6053-6061. PubMed ID: 34951232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative bioavailability of two oral formulations of piroxicam 20 mg: a single-dose, randomized-sequence, open-label, two-period crossover comparison in healthy Mexican adult volunteers.
    Palma-Aguirre JA; Lopez-Gamboa M; Cariño L; Burke-Fraga V; González-de la Parra M
    Clin Ther; 2010 Feb; 32(2):357-64. PubMed ID: 20206793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid-state, triboelectrostatic and dissolution characteristics of spray-dried piroxicam-glucosamine solid dispersions.
    Adebisi AO; Kaialy W; Hussain T; Al-Hamidi H; Nokhodchi A; Conway BR; Asare-Addo K
    Colloids Surf B Biointerfaces; 2016 Oct; 146():841-51. PubMed ID: 27451373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.